nodes	percent_of_prediction	percent_of_DWPC	metapath
Bumetanide—CA9—hematologic cancer	0.248	1	CbGaD
Bumetanide—CA14—Imatinib—hematologic cancer	0.0436	0.0913	CbGbCtD
Bumetanide—CA14—Nilotinib—hematologic cancer	0.0396	0.083	CbGbCtD
Bumetanide—CA7—Imatinib—hematologic cancer	0.0361	0.0756	CbGbCtD
Bumetanide—CA7—Nilotinib—hematologic cancer	0.0328	0.0687	CbGbCtD
Bumetanide—CA12—Imatinib—hematologic cancer	0.031	0.0648	CbGbCtD
Bumetanide—CA9—Imatinib—hematologic cancer	0.031	0.0648	CbGbCtD
Bumetanide—SLCO1A2—Chlorambucil—hematologic cancer	0.0293	0.0614	CbGbCtD
Bumetanide—PTGS2—Lenalidomide—hematologic cancer	0.029	0.0607	CbGbCtD
Bumetanide—CA12—Nilotinib—hematologic cancer	0.0281	0.0589	CbGbCtD
Bumetanide—CA9—Nilotinib—hematologic cancer	0.0281	0.0589	CbGbCtD
Bumetanide—CA4—Nilotinib—hematologic cancer	0.0247	0.0518	CbGbCtD
Bumetanide—PTGS2—Thalidomide—hematologic cancer	0.0155	0.0324	CbGbCtD
Bumetanide—SLC22A8—Mercaptopurine—hematologic cancer	0.014	0.0293	CbGbCtD
Bumetanide—SLCO1A2—Prednisolone—hematologic cancer	0.0111	0.0232	CbGbCtD
Bumetanide—PTGS2—Triamcinolone—hematologic cancer	0.0107	0.0225	CbGbCtD
Bumetanide—SLCO1A2—Prednisone—hematologic cancer	0.0105	0.0219	CbGbCtD
Bumetanide—PTGS2—Betamethasone—hematologic cancer	0.0092	0.0193	CbGbCtD
Bumetanide—SLC22A11—Methotrexate—hematologic cancer	0.00786	0.0165	CbGbCtD
Bumetanide—SLC22A7—Methotrexate—hematologic cancer	0.00748	0.0157	CbGbCtD
Bumetanide—PTGS2—Cisplatin—hematologic cancer	0.00662	0.0139	CbGbCtD
Bumetanide—SLCO1A2—Dexamethasone—hematologic cancer	0.00653	0.0137	CbGbCtD
Bumetanide—PTGS2—Etoposide—hematologic cancer	0.00651	0.0136	CbGbCtD
Bumetanide—PTGS2—Dexamethasone—hematologic cancer	0.00535	0.0112	CbGbCtD
Bumetanide—SLCO1A2—Methotrexate—hematologic cancer	0.00525	0.011	CbGbCtD
Bumetanide—SLC22A8—Methotrexate—hematologic cancer	0.00457	0.00957	CbGbCtD
Bumetanide—PTGS2—ovarian follicle—hematologic cancer	0.00372	0.0897	CbGeAlD
Bumetanide—SLC22A6—Methotrexate—hematologic cancer	0.00318	0.00667	CbGbCtD
Bumetanide—CFTR—hematopoietic system—hematologic cancer	0.00185	0.0447	CbGeAlD
Bumetanide—SLC12A4—gonad—hematologic cancer	0.00179	0.0432	CbGeAlD
Bumetanide—SLC12A2—hematopoietic system—hematologic cancer	0.00163	0.0392	CbGeAlD
Bumetanide—SLC12A5—testis—hematologic cancer	0.00156	0.0375	CbGeAlD
Bumetanide—SLC12A4—lung—hematologic cancer	0.00137	0.033	CbGeAlD
Bumetanide—SLC12A1—hematopoietic system—hematologic cancer	0.00136	0.0329	CbGeAlD
Bumetanide—SLC12A4—testis—hematologic cancer	0.00129	0.0312	CbGeAlD
Bumetanide—SLC12A2—gonad—hematologic cancer	0.00124	0.0298	CbGeAlD
Bumetanide—CFTR—blood—hematologic cancer	0.00123	0.0296	CbGeAlD
Bumetanide—SLC10A1—gonad—hematologic cancer	0.00117	0.0282	CbGeAlD
Bumetanide—SLC12A2—blood—hematologic cancer	0.00108	0.026	CbGeAlD
Bumetanide—CFTR—lung—hematologic cancer	0.00108	0.0259	CbGeAlD
Bumetanide—CA5B—hematopoietic system—hematologic cancer	0.00106	0.0256	CbGeAlD
Bumetanide—SLC12A2—bone marrow—hematologic cancer	0.00104	0.0251	CbGeAlD
Bumetanide—CFTR—testis—hematologic cancer	0.00101	0.0245	CbGeAlD
Bumetanide—SLC12A2—lung—hematologic cancer	0.000945	0.0228	CbGeAlD
Bumetanide—SLC12A4—lymph node—hematologic cancer	0.000936	0.0226	CbGeAlD
Bumetanide—SLC12A1—blood—hematologic cancer	0.000903	0.0218	CbGeAlD
Bumetanide—SLC12A2—testis—hematologic cancer	0.000891	0.0215	CbGeAlD
Bumetanide—CA9—testis—hematologic cancer	0.000878	0.0212	CbGeAlD
Bumetanide—Furosemide—CA9—hematologic cancer	0.000874	0.436	CrCbGaD
Bumetanide—SLC10A1—testis—hematologic cancer	0.000842	0.0203	CbGeAlD
Bumetanide—SLCO1A2—hematopoietic system—hematologic cancer	0.000829	0.02	CbGeAlD
Bumetanide—CA5B—gonad—hematologic cancer	0.000808	0.0195	CbGeAlD
Bumetanide—SLC22A8—hematopoietic system—hematologic cancer	0.000792	0.0191	CbGeAlD
Bumetanide—Indapamide—CA9—hematologic cancer	0.000754	0.376	CrCbGaD
Bumetanide—SLC22A7—testis—hematologic cancer	0.000751	0.0181	CbGeAlD
Bumetanide—SLC12A1—testis—hematologic cancer	0.000747	0.018	CbGeAlD
Bumetanide—CA5B—blood—hematologic cancer	0.000704	0.017	CbGeAlD
Bumetanide—CA12—lung—hematologic cancer	0.000688	0.0166	CbGeAlD
Bumetanide—SLC12A2—lymph node—hematologic cancer	0.000646	0.0156	CbGeAlD
Bumetanide—CA5B—lung—hematologic cancer	0.000617	0.0149	CbGeAlD
Bumetanide—CA5B—testis—hematologic cancer	0.000582	0.014	CbGeAlD
Bumetanide—SLC22A8—blood—hematologic cancer	0.000524	0.0126	CbGeAlD
Bumetanide—CA4—blood—hematologic cancer	0.000486	0.0117	CbGeAlD
Bumetanide—SLCO1A2—lung—hematologic cancer	0.000482	0.0116	CbGeAlD
Bumetanide—CA4—bone marrow—hematologic cancer	0.00047	0.0113	CbGeAlD
Bumetanide—SLCO1A2—testis—hematologic cancer	0.000454	0.011	CbGeAlD
Bumetanide—PTGS2—hematopoietic system—hematologic cancer	0.000449	0.0108	CbGeAlD
Bumetanide—CA4—lung—hematologic cancer	0.000426	0.0103	CbGeAlD
Bumetanide—CA5B—lymph node—hematologic cancer	0.000422	0.0102	CbGeAlD
Bumetanide—CA4—testis—hematologic cancer	0.000402	0.00969	CbGeAlD
Bumetanide—PTGS2—blood—hematologic cancer	0.000297	0.00717	CbGeAlD
Bumetanide—CA4—lymph node—hematologic cancer	0.000291	0.00703	CbGeAlD
Bumetanide—PTGS2—Fluocinonide—Betamethasone—hematologic cancer	0.000289	0.21	CbGdCrCtD
Bumetanide—PTGS2—Fluocinonide—Dexamethasone—hematologic cancer	0.000289	0.21	CbGdCrCtD
Bumetanide—PTGS2—bone marrow—hematologic cancer	0.000288	0.00694	CbGeAlD
Bumetanide—PTGS2—Fluocinonide—Triamcinolone—hematologic cancer	0.000282	0.205	CbGdCrCtD
Bumetanide—PTGS2—lung—hematologic cancer	0.000261	0.00629	CbGeAlD
Bumetanide—Furosemide—ALB—hematologic cancer	0.00022	0.11	CrCbGaD
Bumetanide—PTGS2—lymph node—hematologic cancer	0.000178	0.0043	CbGeAlD
Bumetanide—PTGS2—Fluticasone Propionate—Dexamethasone—hematologic cancer	0.000174	0.126	CbGdCrCtD
Bumetanide—PTGS2—Fluticasone Propionate—Betamethasone—hematologic cancer	0.000174	0.126	CbGdCrCtD
Bumetanide—PTGS2—Fluticasone Propionate—Triamcinolone—hematologic cancer	0.00017	0.124	CbGdCrCtD
Bumetanide—Fenoprofen—ALB—hematologic cancer	0.000158	0.0787	CrCbGaD
Bumetanide—Vomiting—Bortezomib—hematologic cancer	5.26e-05	0.000332	CcSEcCtD
Bumetanide—Vomiting—Bleomycin—hematologic cancer	5.22e-05	0.000329	CcSEcCtD
Bumetanide—Rash—Bortezomib—hematologic cancer	5.22e-05	0.000329	CcSEcCtD
Bumetanide—Dermatitis—Bortezomib—hematologic cancer	5.21e-05	0.000329	CcSEcCtD
Bumetanide—Headache—Bortezomib—hematologic cancer	5.18e-05	0.000327	CcSEcCtD
Bumetanide—Hypotension—Etoposide—hematologic cancer	5.18e-05	0.000327	CcSEcCtD
Bumetanide—Rash—Bleomycin—hematologic cancer	5.18e-05	0.000326	CcSEcCtD
Bumetanide—Dermatitis—Bleomycin—hematologic cancer	5.17e-05	0.000326	CcSEcCtD
Bumetanide—Stevens-Johnson syndrome—Methotrexate—hematologic cancer	5.16e-05	0.000325	CcSEcCtD
Bumetanide—Asthenia—Carmustine—hematologic cancer	5.14e-05	0.000324	CcSEcCtD
Bumetanide—Vomiting—Vinorelbine—hematologic cancer	5.14e-05	0.000324	CcSEcCtD
Bumetanide—Dry mouth—Triamcinolone—hematologic cancer	5.13e-05	0.000323	CcSEcCtD
Bumetanide—Renal failure—Methotrexate—hematologic cancer	5.12e-05	0.000323	CcSEcCtD
Bumetanide—Diarrhoea—Thalidomide—hematologic cancer	5.11e-05	0.000322	CcSEcCtD
Bumetanide—Dizziness—Thiotepa—hematologic cancer	5.1e-05	0.000322	CcSEcCtD
Bumetanide—Asthenia—Alitretinoin—hematologic cancer	5.1e-05	0.000321	CcSEcCtD
Bumetanide—Rash—Vinorelbine—hematologic cancer	5.1e-05	0.000321	CcSEcCtD
Bumetanide—Dermatitis—Vinorelbine—hematologic cancer	5.09e-05	0.000321	CcSEcCtD
Bumetanide—Headache—Vinorelbine—hematologic cancer	5.06e-05	0.000319	CcSEcCtD
Bumetanide—Asthenia—Ifosfamide—hematologic cancer	5.04e-05	0.000318	CcSEcCtD
Bumetanide—Pruritus—Alitretinoin—hematologic cancer	5.02e-05	0.000317	CcSEcCtD
Bumetanide—Vertigo—Betamethasone—hematologic cancer	5.02e-05	0.000317	CcSEcCtD
Bumetanide—Vertigo—Dexamethasone—hematologic cancer	5.02e-05	0.000317	CcSEcCtD
Bumetanide—Sweating—Methotrexate—hematologic cancer	4.99e-05	0.000315	CcSEcCtD
Bumetanide—Pruritus—Ifosfamide—hematologic cancer	4.97e-05	0.000313	CcSEcCtD
Bumetanide—Pancreatitis—Doxorubicin—hematologic cancer	4.96e-05	0.000313	CcSEcCtD
Bumetanide—Dizziness—Thalidomide—hematologic cancer	4.94e-05	0.000311	CcSEcCtD
Bumetanide—Hyperglycaemia—Epirubicin—hematologic cancer	4.93e-05	0.000311	CcSEcCtD
Bumetanide—Nausea—Bortezomib—hematologic cancer	4.92e-05	0.00031	CcSEcCtD
Bumetanide—Asthenia—Vincristine—hematologic cancer	4.91e-05	0.00031	CcSEcCtD
Bumetanide—Vomiting—Thiotepa—hematologic cancer	4.91e-05	0.000309	CcSEcCtD
Bumetanide—Diarrhoea—Carmustine—hematologic cancer	4.91e-05	0.000309	CcSEcCtD
Bumetanide—Nausea—Bleomycin—hematologic cancer	4.88e-05	0.000308	CcSEcCtD
Bumetanide—Rash—Thiotepa—hematologic cancer	4.87e-05	0.000307	CcSEcCtD
Bumetanide—Dermatitis—Thiotepa—hematologic cancer	4.86e-05	0.000307	CcSEcCtD
Bumetanide—Hyperhidrosis—Triamcinolone—hematologic cancer	4.86e-05	0.000306	CcSEcCtD
Bumetanide—Diarrhoea—Alitretinoin—hematologic cancer	4.86e-05	0.000306	CcSEcCtD
Bumetanide—Headache—Thiotepa—hematologic cancer	4.83e-05	0.000305	CcSEcCtD
Bumetanide—Stevens-Johnson syndrome—Epirubicin—hematologic cancer	4.83e-05	0.000305	CcSEcCtD
Bumetanide—Diarrhoea—Ifosfamide—hematologic cancer	4.8e-05	0.000303	CcSEcCtD
Bumetanide—Nausea—Vinorelbine—hematologic cancer	4.8e-05	0.000303	CcSEcCtD
Bumetanide—Renal failure—Epirubicin—hematologic cancer	4.79e-05	0.000302	CcSEcCtD
Bumetanide—Asthenia—Mitoxantrone—hematologic cancer	4.78e-05	0.000301	CcSEcCtD
Bumetanide—Asthenia—Irinotecan—hematologic cancer	4.78e-05	0.000301	CcSEcCtD
Bumetanide—Fatigue—Etoposide—hematologic cancer	4.78e-05	0.000301	CcSEcCtD
Bumetanide—Vomiting—Thalidomide—hematologic cancer	4.75e-05	0.000299	CcSEcCtD
Bumetanide—Dizziness—Carmustine—hematologic cancer	4.74e-05	0.000299	CcSEcCtD
Bumetanide—Rash—Thalidomide—hematologic cancer	4.71e-05	0.000297	CcSEcCtD
Bumetanide—Dermatitis—Thalidomide—hematologic cancer	4.7e-05	0.000296	CcSEcCtD
Bumetanide—Dizziness—Alitretinoin—hematologic cancer	4.7e-05	0.000296	CcSEcCtD
Bumetanide—Diarrhoea—Vincristine—hematologic cancer	4.68e-05	0.000295	CcSEcCtD
Bumetanide—Headache—Thalidomide—hematologic cancer	4.68e-05	0.000295	CcSEcCtD
Bumetanide—Sweating—Epirubicin—hematologic cancer	4.67e-05	0.000294	CcSEcCtD
Bumetanide—Asthenia—Gemcitabine—hematologic cancer	4.66e-05	0.000294	CcSEcCtD
Bumetanide—Dizziness—Ifosfamide—hematologic cancer	4.64e-05	0.000293	CcSEcCtD
Bumetanide—Pruritus—Gemcitabine—hematologic cancer	4.59e-05	0.00029	CcSEcCtD
Bumetanide—Nausea—Thiotepa—hematologic cancer	4.58e-05	0.000289	CcSEcCtD
Bumetanide—Hyperglycaemia—Doxorubicin—hematologic cancer	4.56e-05	0.000288	CcSEcCtD
Bumetanide—Diarrhoea—Irinotecan—hematologic cancer	4.56e-05	0.000287	CcSEcCtD
Bumetanide—Diarrhoea—Mitoxantrone—hematologic cancer	4.56e-05	0.000287	CcSEcCtD
Bumetanide—Vomiting—Carmustine—hematologic cancer	4.56e-05	0.000287	CcSEcCtD
Bumetanide—Gastrointestinal pain—Etoposide—hematologic cancer	4.53e-05	0.000286	CcSEcCtD
Bumetanide—Dizziness—Vincristine—hematologic cancer	4.53e-05	0.000285	CcSEcCtD
Bumetanide—Rash—Carmustine—hematologic cancer	4.52e-05	0.000285	CcSEcCtD
Bumetanide—Dermatitis—Carmustine—hematologic cancer	4.52e-05	0.000285	CcSEcCtD
Bumetanide—Vomiting—Alitretinoin—hematologic cancer	4.52e-05	0.000285	CcSEcCtD
Bumetanide—Headache—Carmustine—hematologic cancer	4.49e-05	0.000283	CcSEcCtD
Bumetanide—Rash—Alitretinoin—hematologic cancer	4.48e-05	0.000282	CcSEcCtD
Bumetanide—Dermatitis—Alitretinoin—hematologic cancer	4.47e-05	0.000282	CcSEcCtD
Bumetanide—Stevens-Johnson syndrome—Doxorubicin—hematologic cancer	4.47e-05	0.000282	CcSEcCtD
Bumetanide—Thrombocytopenia—Betamethasone—hematologic cancer	4.47e-05	0.000282	CcSEcCtD
Bumetanide—Thrombocytopenia—Dexamethasone—hematologic cancer	4.47e-05	0.000282	CcSEcCtD
Bumetanide—Vomiting—Ifosfamide—hematologic cancer	4.46e-05	0.000281	CcSEcCtD
Bumetanide—Headache—Alitretinoin—hematologic cancer	4.45e-05	0.000281	CcSEcCtD
Bumetanide—Diarrhoea—Gemcitabine—hematologic cancer	4.44e-05	0.00028	CcSEcCtD
Bumetanide—Nausea—Thalidomide—hematologic cancer	4.43e-05	0.00028	CcSEcCtD
Bumetanide—Renal failure—Doxorubicin—hematologic cancer	4.43e-05	0.000279	CcSEcCtD
Bumetanide—Rash—Ifosfamide—hematologic cancer	4.43e-05	0.000279	CcSEcCtD
Bumetanide—Dermatitis—Ifosfamide—hematologic cancer	4.42e-05	0.000279	CcSEcCtD
Bumetanide—Erythema multiforme—Methotrexate—hematologic cancer	4.42e-05	0.000279	CcSEcCtD
Bumetanide—Hyperhidrosis—Betamethasone—hematologic cancer	4.41e-05	0.000278	CcSEcCtD
Bumetanide—Hyperhidrosis—Dexamethasone—hematologic cancer	4.41e-05	0.000278	CcSEcCtD
Bumetanide—Dizziness—Irinotecan—hematologic cancer	4.41e-05	0.000278	CcSEcCtD
Bumetanide—Urticaria—Etoposide—hematologic cancer	4.4e-05	0.000278	CcSEcCtD
Bumetanide—Abdominal pain—Etoposide—hematologic cancer	4.38e-05	0.000276	CcSEcCtD
Bumetanide—Vertigo—Prednisone—hematologic cancer	4.37e-05	0.000276	CcSEcCtD
Bumetanide—Vomiting—Vincristine—hematologic cancer	4.35e-05	0.000274	CcSEcCtD
Bumetanide—Urticaria—Prednisolone—hematologic cancer	4.34e-05	0.000274	CcSEcCtD
Bumetanide—Asthenia—Cisplatin—hematologic cancer	4.34e-05	0.000274	CcSEcCtD
Bumetanide—Fatigue—Triamcinolone—hematologic cancer	4.34e-05	0.000273	CcSEcCtD
Bumetanide—Sweating—Doxorubicin—hematologic cancer	4.32e-05	0.000272	CcSEcCtD
Bumetanide—Rash—Vincristine—hematologic cancer	4.31e-05	0.000272	CcSEcCtD
Bumetanide—Dermatitis—Vincristine—hematologic cancer	4.31e-05	0.000272	CcSEcCtD
Bumetanide—Headache—Vincristine—hematologic cancer	4.29e-05	0.00027	CcSEcCtD
Bumetanide—Hypotension—Betamethasone—hematologic cancer	4.26e-05	0.000269	CcSEcCtD
Bumetanide—Hypotension—Dexamethasone—hematologic cancer	4.26e-05	0.000269	CcSEcCtD
Bumetanide—Nausea—Carmustine—hematologic cancer	4.26e-05	0.000268	CcSEcCtD
Bumetanide—Vomiting—Irinotecan—hematologic cancer	4.24e-05	0.000267	CcSEcCtD
Bumetanide—Vomiting—Mitoxantrone—hematologic cancer	4.24e-05	0.000267	CcSEcCtD
Bumetanide—Nausea—Alitretinoin—hematologic cancer	4.22e-05	0.000266	CcSEcCtD
Bumetanide—Rash—Mitoxantrone—hematologic cancer	4.2e-05	0.000265	CcSEcCtD
Bumetanide—Rash—Irinotecan—hematologic cancer	4.2e-05	0.000265	CcSEcCtD
Bumetanide—Dermatitis—Mitoxantrone—hematologic cancer	4.2e-05	0.000265	CcSEcCtD
Bumetanide—Dermatitis—Irinotecan—hematologic cancer	4.2e-05	0.000265	CcSEcCtD
Bumetanide—Headache—Irinotecan—hematologic cancer	4.18e-05	0.000263	CcSEcCtD
Bumetanide—Headache—Mitoxantrone—hematologic cancer	4.18e-05	0.000263	CcSEcCtD
Bumetanide—Nausea—Ifosfamide—hematologic cancer	4.17e-05	0.000263	CcSEcCtD
Bumetanide—Arthralgia—Prednisone—hematologic cancer	4.14e-05	0.000261	CcSEcCtD
Bumetanide—Diarrhoea—Cisplatin—hematologic cancer	4.14e-05	0.000261	CcSEcCtD
Bumetanide—Erythema multiforme—Epirubicin—hematologic cancer	4.14e-05	0.000261	CcSEcCtD
Bumetanide—Vomiting—Gemcitabine—hematologic cancer	4.13e-05	0.00026	CcSEcCtD
Bumetanide—Rash—Gemcitabine—hematologic cancer	4.09e-05	0.000258	CcSEcCtD
Bumetanide—Dermatitis—Gemcitabine—hematologic cancer	4.09e-05	0.000258	CcSEcCtD
Bumetanide—Headache—Gemcitabine—hematologic cancer	4.07e-05	0.000256	CcSEcCtD
Bumetanide—Nausea—Vincristine—hematologic cancer	4.06e-05	0.000256	CcSEcCtD
Bumetanide—Urticaria—Triamcinolone—hematologic cancer	3.99e-05	0.000252	CcSEcCtD
Bumetanide—Asthenia—Etoposide—hematologic cancer	3.98e-05	0.000251	CcSEcCtD
Bumetanide—Nausea—Irinotecan—hematologic cancer	3.96e-05	0.00025	CcSEcCtD
Bumetanide—Nausea—Mitoxantrone—hematologic cancer	3.96e-05	0.00025	CcSEcCtD
Bumetanide—Fatigue—Betamethasone—hematologic cancer	3.93e-05	0.000248	CcSEcCtD
Bumetanide—Fatigue—Dexamethasone—hematologic cancer	3.93e-05	0.000248	CcSEcCtD
Bumetanide—Pruritus—Etoposide—hematologic cancer	3.92e-05	0.000247	CcSEcCtD
Bumetanide—Nausea—Gemcitabine—hematologic cancer	3.86e-05	0.000243	CcSEcCtD
Bumetanide—Vomiting—Cisplatin—hematologic cancer	3.85e-05	0.000243	CcSEcCtD
Bumetanide—Hyperhidrosis—Prednisone—hematologic cancer	3.84e-05	0.000242	CcSEcCtD
Bumetanide—Erythema multiforme—Doxorubicin—hematologic cancer	3.83e-05	0.000241	CcSEcCtD
Bumetanide—Rash—Cisplatin—hematologic cancer	3.82e-05	0.000241	CcSEcCtD
Bumetanide—Dermatitis—Cisplatin—hematologic cancer	3.81e-05	0.00024	CcSEcCtD
Bumetanide—Diarrhoea—Etoposide—hematologic cancer	3.79e-05	0.000239	CcSEcCtD
Bumetanide—Gastrointestinal pain—Betamethasone—hematologic cancer	3.73e-05	0.000235	CcSEcCtD
Bumetanide—Gastrointestinal pain—Dexamethasone—hematologic cancer	3.73e-05	0.000235	CcSEcCtD
Bumetanide—Dizziness—Etoposide—hematologic cancer	3.67e-05	0.000231	CcSEcCtD
Bumetanide—Muscle spasms—Epirubicin—hematologic cancer	3.66e-05	0.000231	CcSEcCtD
Bumetanide—Vertigo—Methotrexate—hematologic cancer	3.66e-05	0.00023	CcSEcCtD
Bumetanide—Leukopenia—Methotrexate—hematologic cancer	3.64e-05	0.00023	CcSEcCtD
Bumetanide—Urticaria—Dexamethasone—hematologic cancer	3.62e-05	0.000229	CcSEcCtD
Bumetanide—Urticaria—Betamethasone—hematologic cancer	3.62e-05	0.000229	CcSEcCtD
Bumetanide—Dizziness—Prednisolone—hematologic cancer	3.62e-05	0.000228	CcSEcCtD
Bumetanide—Asthenia—Triamcinolone—hematologic cancer	3.61e-05	0.000227	CcSEcCtD
Bumetanide—Abdominal pain—Betamethasone—hematologic cancer	3.61e-05	0.000227	CcSEcCtD
Bumetanide—Abdominal pain—Dexamethasone—hematologic cancer	3.61e-05	0.000227	CcSEcCtD
Bumetanide—Nausea—Cisplatin—hematologic cancer	3.59e-05	0.000227	CcSEcCtD
Bumetanide—Pruritus—Triamcinolone—hematologic cancer	3.56e-05	0.000224	CcSEcCtD
Bumetanide—Vomiting—Etoposide—hematologic cancer	3.52e-05	0.000222	CcSEcCtD
Bumetanide—Rash—Etoposide—hematologic cancer	3.5e-05	0.00022	CcSEcCtD
Bumetanide—Dermatitis—Etoposide—hematologic cancer	3.49e-05	0.00022	CcSEcCtD
Bumetanide—Headache—Etoposide—hematologic cancer	3.47e-05	0.000219	CcSEcCtD
Bumetanide—Chest pain—Methotrexate—hematologic cancer	3.46e-05	0.000218	CcSEcCtD
Bumetanide—Arthralgia—Methotrexate—hematologic cancer	3.46e-05	0.000218	CcSEcCtD
Bumetanide—Rash—Prednisolone—hematologic cancer	3.45e-05	0.000217	CcSEcCtD
Bumetanide—Dermatitis—Prednisolone—hematologic cancer	3.44e-05	0.000217	CcSEcCtD
Bumetanide—Fatigue—Prednisone—hematologic cancer	3.43e-05	0.000216	CcSEcCtD
Bumetanide—Headache—Prednisolone—hematologic cancer	3.43e-05	0.000216	CcSEcCtD
Bumetanide—Vertigo—Epirubicin—hematologic cancer	3.42e-05	0.000216	CcSEcCtD
Bumetanide—Leukopenia—Epirubicin—hematologic cancer	3.41e-05	0.000215	CcSEcCtD
Bumetanide—Muscle spasms—Doxorubicin—hematologic cancer	3.39e-05	0.000214	CcSEcCtD
Bumetanide—Dizziness—Triamcinolone—hematologic cancer	3.33e-05	0.00021	CcSEcCtD
Bumetanide—Nausea—Etoposide—hematologic cancer	3.29e-05	0.000208	CcSEcCtD
Bumetanide—Asthenia—Dexamethasone—hematologic cancer	3.27e-05	0.000206	CcSEcCtD
Bumetanide—Asthenia—Betamethasone—hematologic cancer	3.27e-05	0.000206	CcSEcCtD
Bumetanide—Thrombocytopenia—Methotrexate—hematologic cancer	3.25e-05	0.000205	CcSEcCtD
Bumetanide—Gastrointestinal pain—Prednisone—hematologic cancer	3.25e-05	0.000205	CcSEcCtD
Bumetanide—Nausea—Prednisolone—hematologic cancer	3.25e-05	0.000205	CcSEcCtD
Bumetanide—Chest pain—Epirubicin—hematologic cancer	3.24e-05	0.000204	CcSEcCtD
Bumetanide—Arthralgia—Epirubicin—hematologic cancer	3.24e-05	0.000204	CcSEcCtD
Bumetanide—Pruritus—Dexamethasone—hematologic cancer	3.23e-05	0.000204	CcSEcCtD
Bumetanide—Pruritus—Betamethasone—hematologic cancer	3.23e-05	0.000204	CcSEcCtD
Bumetanide—Hyperhidrosis—Methotrexate—hematologic cancer	3.21e-05	0.000202	CcSEcCtD
Bumetanide—Vomiting—Triamcinolone—hematologic cancer	3.2e-05	0.000202	CcSEcCtD
Bumetanide—Rash—Triamcinolone—hematologic cancer	3.17e-05	0.0002	CcSEcCtD
Bumetanide—Dry mouth—Epirubicin—hematologic cancer	3.17e-05	0.0002	CcSEcCtD
Bumetanide—Dermatitis—Triamcinolone—hematologic cancer	3.17e-05	0.0002	CcSEcCtD
Bumetanide—Vertigo—Doxorubicin—hematologic cancer	3.17e-05	0.0002	CcSEcCtD
Bumetanide—Urticaria—Prednisone—hematologic cancer	3.16e-05	0.000199	CcSEcCtD
Bumetanide—Leukopenia—Doxorubicin—hematologic cancer	3.15e-05	0.000199	CcSEcCtD
Bumetanide—Headache—Triamcinolone—hematologic cancer	3.15e-05	0.000199	CcSEcCtD
Bumetanide—Abdominal pain—Prednisone—hematologic cancer	3.14e-05	0.000198	CcSEcCtD
Bumetanide—Diarrhoea—Betamethasone—hematologic cancer	3.12e-05	0.000197	CcSEcCtD
Bumetanide—Diarrhoea—Dexamethasone—hematologic cancer	3.12e-05	0.000197	CcSEcCtD
Bumetanide—Hypotension—Methotrexate—hematologic cancer	3.1e-05	0.000196	CcSEcCtD
Bumetanide—Thrombocytopenia—Epirubicin—hematologic cancer	3.04e-05	0.000192	CcSEcCtD
Bumetanide—Dizziness—Dexamethasone—hematologic cancer	3.02e-05	0.00019	CcSEcCtD
Bumetanide—Dizziness—Betamethasone—hematologic cancer	3.02e-05	0.00019	CcSEcCtD
Bumetanide—Hyperhidrosis—Epirubicin—hematologic cancer	3e-05	0.000189	CcSEcCtD
Bumetanide—Arthralgia—Doxorubicin—hematologic cancer	3e-05	0.000189	CcSEcCtD
Bumetanide—Chest pain—Doxorubicin—hematologic cancer	3e-05	0.000189	CcSEcCtD
Bumetanide—Nausea—Triamcinolone—hematologic cancer	2.99e-05	0.000188	CcSEcCtD
Bumetanide—Dry mouth—Doxorubicin—hematologic cancer	2.93e-05	0.000185	CcSEcCtD
Bumetanide—Hypotension—Epirubicin—hematologic cancer	2.9e-05	0.000183	CcSEcCtD
Bumetanide—Vomiting—Betamethasone—hematologic cancer	2.9e-05	0.000183	CcSEcCtD
Bumetanide—Vomiting—Dexamethasone—hematologic cancer	2.9e-05	0.000183	CcSEcCtD
Bumetanide—Rash—Betamethasone—hematologic cancer	2.88e-05	0.000181	CcSEcCtD
Bumetanide—Rash—Dexamethasone—hematologic cancer	2.88e-05	0.000181	CcSEcCtD
Bumetanide—Dermatitis—Betamethasone—hematologic cancer	2.87e-05	0.000181	CcSEcCtD
Bumetanide—Dermatitis—Dexamethasone—hematologic cancer	2.87e-05	0.000181	CcSEcCtD
Bumetanide—Fatigue—Methotrexate—hematologic cancer	2.86e-05	0.00018	CcSEcCtD
Bumetanide—Headache—Betamethasone—hematologic cancer	2.86e-05	0.00018	CcSEcCtD
Bumetanide—Headache—Dexamethasone—hematologic cancer	2.86e-05	0.00018	CcSEcCtD
Bumetanide—Asthenia—Prednisone—hematologic cancer	2.85e-05	0.00018	CcSEcCtD
Bumetanide—Thrombocytopenia—Doxorubicin—hematologic cancer	2.82e-05	0.000177	CcSEcCtD
Bumetanide—Pruritus—Prednisone—hematologic cancer	2.81e-05	0.000177	CcSEcCtD
Bumetanide—Hyperhidrosis—Doxorubicin—hematologic cancer	2.78e-05	0.000175	CcSEcCtD
Bumetanide—Diarrhoea—Prednisone—hematologic cancer	2.72e-05	0.000171	CcSEcCtD
Bumetanide—Gastrointestinal pain—Methotrexate—hematologic cancer	2.72e-05	0.000171	CcSEcCtD
Bumetanide—Nausea—Betamethasone—hematologic cancer	2.71e-05	0.000171	CcSEcCtD
Bumetanide—Nausea—Dexamethasone—hematologic cancer	2.71e-05	0.000171	CcSEcCtD
Bumetanide—Hypotension—Doxorubicin—hematologic cancer	2.69e-05	0.000169	CcSEcCtD
Bumetanide—Fatigue—Epirubicin—hematologic cancer	2.68e-05	0.000169	CcSEcCtD
Bumetanide—Urticaria—Methotrexate—hematologic cancer	2.64e-05	0.000166	CcSEcCtD
Bumetanide—Dizziness—Prednisone—hematologic cancer	2.63e-05	0.000166	CcSEcCtD
Bumetanide—Abdominal pain—Methotrexate—hematologic cancer	2.62e-05	0.000165	CcSEcCtD
Bumetanide—Gastrointestinal pain—Epirubicin—hematologic cancer	2.54e-05	0.00016	CcSEcCtD
Bumetanide—Vomiting—Prednisone—hematologic cancer	2.53e-05	0.000159	CcSEcCtD
Bumetanide—Rash—Prednisone—hematologic cancer	2.51e-05	0.000158	CcSEcCtD
Bumetanide—Dermatitis—Prednisone—hematologic cancer	2.5e-05	0.000158	CcSEcCtD
Bumetanide—Headache—Prednisone—hematologic cancer	2.49e-05	0.000157	CcSEcCtD
Bumetanide—Fatigue—Doxorubicin—hematologic cancer	2.48e-05	0.000156	CcSEcCtD
Bumetanide—Urticaria—Epirubicin—hematologic cancer	2.47e-05	0.000156	CcSEcCtD
Bumetanide—Abdominal pain—Epirubicin—hematologic cancer	2.46e-05	0.000155	CcSEcCtD
Bumetanide—Asthenia—Methotrexate—hematologic cancer	2.38e-05	0.00015	CcSEcCtD
Bumetanide—Nausea—Prednisone—hematologic cancer	2.36e-05	0.000149	CcSEcCtD
Bumetanide—Gastrointestinal pain—Doxorubicin—hematologic cancer	2.35e-05	0.000148	CcSEcCtD
Bumetanide—Pruritus—Methotrexate—hematologic cancer	2.35e-05	0.000148	CcSEcCtD
Bumetanide—Urticaria—Doxorubicin—hematologic cancer	2.28e-05	0.000144	CcSEcCtD
Bumetanide—Abdominal pain—Doxorubicin—hematologic cancer	2.27e-05	0.000143	CcSEcCtD
Bumetanide—Diarrhoea—Methotrexate—hematologic cancer	2.27e-05	0.000143	CcSEcCtD
Bumetanide—Asthenia—Epirubicin—hematologic cancer	2.23e-05	0.000141	CcSEcCtD
Bumetanide—Pruritus—Epirubicin—hematologic cancer	2.2e-05	0.000139	CcSEcCtD
Bumetanide—Dizziness—Methotrexate—hematologic cancer	2.2e-05	0.000138	CcSEcCtD
Bumetanide—Diarrhoea—Epirubicin—hematologic cancer	2.13e-05	0.000134	CcSEcCtD
Bumetanide—Vomiting—Methotrexate—hematologic cancer	2.11e-05	0.000133	CcSEcCtD
Bumetanide—Rash—Methotrexate—hematologic cancer	2.09e-05	0.000132	CcSEcCtD
Bumetanide—Dermatitis—Methotrexate—hematologic cancer	2.09e-05	0.000132	CcSEcCtD
Bumetanide—Headache—Methotrexate—hematologic cancer	2.08e-05	0.000131	CcSEcCtD
Bumetanide—Asthenia—Doxorubicin—hematologic cancer	2.06e-05	0.00013	CcSEcCtD
Bumetanide—Dizziness—Epirubicin—hematologic cancer	2.05e-05	0.00013	CcSEcCtD
Bumetanide—Pruritus—Doxorubicin—hematologic cancer	2.03e-05	0.000128	CcSEcCtD
Bumetanide—Vomiting—Epirubicin—hematologic cancer	1.98e-05	0.000125	CcSEcCtD
Bumetanide—Nausea—Methotrexate—hematologic cancer	1.97e-05	0.000124	CcSEcCtD
Bumetanide—Diarrhoea—Doxorubicin—hematologic cancer	1.97e-05	0.000124	CcSEcCtD
Bumetanide—Rash—Epirubicin—hematologic cancer	1.96e-05	0.000124	CcSEcCtD
Bumetanide—Dermatitis—Epirubicin—hematologic cancer	1.96e-05	0.000123	CcSEcCtD
Bumetanide—Headache—Epirubicin—hematologic cancer	1.95e-05	0.000123	CcSEcCtD
Bumetanide—Dizziness—Doxorubicin—hematologic cancer	1.9e-05	0.00012	CcSEcCtD
Bumetanide—Nausea—Epirubicin—hematologic cancer	1.85e-05	0.000116	CcSEcCtD
Bumetanide—Vomiting—Doxorubicin—hematologic cancer	1.83e-05	0.000115	CcSEcCtD
Bumetanide—Rash—Doxorubicin—hematologic cancer	1.81e-05	0.000114	CcSEcCtD
Bumetanide—Dermatitis—Doxorubicin—hematologic cancer	1.81e-05	0.000114	CcSEcCtD
Bumetanide—Headache—Doxorubicin—hematologic cancer	1.8e-05	0.000114	CcSEcCtD
Bumetanide—Nausea—Doxorubicin—hematologic cancer	1.71e-05	0.000108	CcSEcCtD
Bumetanide—CA5A—Metabolism—PIK3CB—hematologic cancer	7.91e-06	0.000112	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—hematologic cancer	7.89e-06	0.000111	CbGpPWpGaD
Bumetanide—CA12—Metabolism—PIK3CD—hematologic cancer	7.84e-06	0.000111	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	7.82e-06	0.00011	CbGpPWpGaD
Bumetanide—PTGS2—Disease—ACP5—hematologic cancer	7.76e-06	0.00011	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—GSTT1—hematologic cancer	7.76e-06	0.000109	CbGpPWpGaD
Bumetanide—CA9—Metabolism—NCOR1—hematologic cancer	7.74e-06	0.000109	CbGpPWpGaD
Bumetanide—CA9—Metabolism—GSTM1—hematologic cancer	7.74e-06	0.000109	CbGpPWpGaD
Bumetanide—CA12—Metabolism—ALB—hematologic cancer	7.74e-06	0.000109	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—hematologic cancer	7.72e-06	0.000109	CbGpPWpGaD
Bumetanide—PTGS2—Disease—NCOR2—hematologic cancer	7.66e-06	0.000108	CbGpPWpGaD
Bumetanide—SLC22A8—Transmembrane transport of small molecules—ALB—hematologic cancer	7.66e-06	0.000108	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—FHL2—hematologic cancer	7.65e-06	0.000108	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	7.64e-06	0.000108	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—SDC1—hematologic cancer	7.58e-06	0.000107	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—hematologic cancer	7.53e-06	0.000106	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—AGRN—hematologic cancer	7.5e-06	0.000106	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—PIK3CG—hematologic cancer	7.46e-06	0.000105	CbGpPWpGaD
Bumetanide—CA12—Metabolism—PIK3R1—hematologic cancer	7.41e-06	0.000105	CbGpPWpGaD
Bumetanide—CA7—Metabolism—PIK3CB—hematologic cancer	7.38e-06	0.000104	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—PIK3CB—hematologic cancer	7.38e-06	0.000104	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—hematologic cancer	7.32e-06	0.000103	CbGpPWpGaD
Bumetanide—PTGS2—Disease—IDH1—hematologic cancer	7.3e-06	0.000103	CbGpPWpGaD
Bumetanide—SLCO1A2—Transmembrane transport of small molecules—CREBBP—hematologic cancer	7.27e-06	0.000103	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—IL6—hematologic cancer	7.25e-06	0.000102	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	7.25e-06	0.000102	CbGpPWpGaD
Bumetanide—PTGS2—Disease—GSTO1—hematologic cancer	7.22e-06	0.000102	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	7.15e-06	0.000101	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—hematologic cancer	7.13e-06	0.000101	CbGpPWpGaD
Bumetanide—CA4—Metabolism—PIK3CG—hematologic cancer	7.12e-06	0.0001	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—IDH2—hematologic cancer	7.11e-06	0.0001	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—HMMR—hematologic cancer	7.11e-06	0.0001	CbGpPWpGaD
Bumetanide—PTGS2—Disease—AGO2—hematologic cancer	7.06e-06	9.96e-05	CbGpPWpGaD
Bumetanide—CA14—Metabolism—PTEN—hematologic cancer	7.01e-06	9.89e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—HDAC9—hematologic cancer	6.99e-06	9.86e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—H3F3B—hematologic cancer	6.92e-06	9.76e-05	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—CREBBP—hematologic cancer	6.92e-06	9.76e-05	CbGpPWpGaD
Bumetanide—CA9—Metabolism—MTHFR—hematologic cancer	6.84e-06	9.66e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	6.84e-06	9.65e-05	CbGpPWpGaD
Bumetanide—CA12—Metabolism—PIK3CB—hematologic cancer	6.84e-06	9.65e-05	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—PTEN—hematologic cancer	6.83e-06	9.64e-05	CbGpPWpGaD
Bumetanide—SLC22A6—Transmembrane transport of small molecules—CREBBP—hematologic cancer	6.83e-06	9.63e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Transmembrane transport of small molecules—ALB—hematologic cancer	6.8e-06	9.59e-05	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—hematologic cancer	6.74e-06	9.51e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	6.7e-06	9.46e-05	CbGpPWpGaD
Bumetanide—CA14—Metabolism—EP300—hematologic cancer	6.69e-06	9.43e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—ARNTL—hematologic cancer	6.68e-06	9.43e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—NPM1—hematologic cancer	6.66e-06	9.4e-05	CbGpPWpGaD
Bumetanide—CA4—Metabolism—CREBBP—hematologic cancer	6.6e-06	9.31e-05	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	6.56e-06	9.25e-05	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—PIK3CD—hematologic cancer	6.56e-06	9.25e-05	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	6.54e-06	9.23e-05	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—EP300—hematologic cancer	6.52e-06	9.19e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—ACP5—hematologic cancer	6.5e-06	9.17e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—CA9—hematologic cancer	6.5e-06	9.17e-05	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—ALB—hematologic cancer	6.47e-06	9.13e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—CD44—hematologic cancer	6.45e-06	9.1e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—NQO1—hematologic cancer	6.45e-06	9.1e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—NCOR2—hematologic cancer	6.42e-06	9.05e-05	CbGpPWpGaD
Bumetanide—SLC22A6—Transmembrane transport of small molecules—ALB—hematologic cancer	6.39e-06	9.02e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—FGF19—hematologic cancer	6.38e-06	9e-05	CbGpPWpGaD
Bumetanide—CA7—Metabolism—PTEN—hematologic cancer	6.38e-06	9e-05	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—PTEN—hematologic cancer	6.38e-06	9e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—RPS14—hematologic cancer	6.33e-06	8.93e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	6.31e-06	8.91e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—DKK1—hematologic cancer	6.28e-06	8.86e-05	CbGpPWpGaD
Bumetanide—CA4—Metabolism—PIK3CD—hematologic cancer	6.26e-06	8.83e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—NUP98—hematologic cancer	6.23e-06	8.79e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—STAT5B—hematologic cancer	6.23e-06	8.79e-05	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—PIK3R1—hematologic cancer	6.19e-06	8.74e-05	CbGpPWpGaD
Bumetanide—CA4—Metabolism—ALB—hematologic cancer	6.18e-06	8.71e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—IDH1—hematologic cancer	6.11e-06	8.62e-05	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	6.11e-06	8.62e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—CYCS—hematologic cancer	6.1e-06	8.61e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—CST3—hematologic cancer	6.09e-06	8.59e-05	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—EP300—hematologic cancer	6.08e-06	8.58e-05	CbGpPWpGaD
Bumetanide—CA7—Metabolism—EP300—hematologic cancer	6.08e-06	8.58e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—HSP90AA1—hematologic cancer	6.06e-06	8.55e-05	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	6.06e-06	8.55e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—ADCY7—hematologic cancer	6.05e-06	8.53e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—ABCC3—hematologic cancer	6.04e-06	8.53e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—GSTO1—hematologic cancer	6.04e-06	8.53e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—TXN—hematologic cancer	6.04e-06	8.53e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—NUP214—hematologic cancer	6.01e-06	8.47e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—SPHK1—hematologic cancer	5.91e-06	8.34e-05	CbGpPWpGaD
Bumetanide—CA12—Metabolism—PTEN—hematologic cancer	5.91e-06	8.34e-05	CbGpPWpGaD
Bumetanide—CA4—Metabolism—PIK3R1—hematologic cancer	5.91e-06	8.33e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—MTR—hematologic cancer	5.88e-06	8.3e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—XIAP—hematologic cancer	5.88e-06	8.3e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—ENO2—hematologic cancer	5.77e-06	8.14e-05	CbGpPWpGaD
Bumetanide—CA9—Metabolism—PIK3CG—hematologic cancer	5.75e-06	8.11e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—SMARCA4—hematologic cancer	5.73e-06	8.09e-05	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—PIK3CB—hematologic cancer	5.72e-06	8.06e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—UGT1A1—hematologic cancer	5.68e-06	8.02e-05	CbGpPWpGaD
Bumetanide—CA12—Metabolism—EP300—hematologic cancer	5.63e-06	7.95e-05	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	5.57e-06	7.85e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—CRABP1—hematologic cancer	5.53e-06	7.8e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—SLC22A1—hematologic cancer	5.53e-06	7.8e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—SDC1—hematologic cancer	5.47e-06	7.72e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	5.46e-06	7.7e-05	CbGpPWpGaD
Bumetanide—CA4—Metabolism—PIK3CB—hematologic cancer	5.45e-06	7.69e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—ALOX5—hematologic cancer	5.39e-06	7.6e-05	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	5.39e-06	7.6e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—GSTP1—hematologic cancer	5.38e-06	7.59e-05	CbGpPWpGaD
Bumetanide—CA9—Metabolism—CREBBP—hematologic cancer	5.33e-06	7.52e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—LCK—hematologic cancer	5.3e-06	7.47e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—NUP98—hematologic cancer	5.22e-06	7.36e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	5.2e-06	7.34e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—H3F3A—hematologic cancer	5.19e-06	7.33e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—ABCB1—hematologic cancer	5.09e-06	7.18e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—NCOA3—hematologic cancer	5.06e-06	7.15e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—ADCY7—hematologic cancer	5.06e-06	7.15e-05	CbGpPWpGaD
Bumetanide—CA9—Metabolism—PIK3CD—hematologic cancer	5.06e-06	7.13e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—PRKCZ—hematologic cancer	5.05e-06	7.12e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—NUP214—hematologic cancer	5.03e-06	7.1e-05	CbGpPWpGaD
Bumetanide—CA9—Metabolism—ALB—hematologic cancer	4.99e-06	7.04e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	4.98e-06	7.02e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—CALR—hematologic cancer	4.96e-06	7e-05	CbGpPWpGaD
Bumetanide—CA14—Metabolism—PIK3CA—hematologic cancer	4.95e-06	6.98e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—NCOR1—hematologic cancer	4.94e-06	6.97e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—GSTM1—hematologic cancer	4.94e-06	6.97e-05	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—PTEN—hematologic cancer	4.94e-06	6.97e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—MTR—hematologic cancer	4.93e-06	6.95e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—ABCG2—hematologic cancer	4.93e-06	6.95e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—PARP1—hematologic cancer	4.87e-06	6.88e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—ENO2—hematologic cancer	4.83e-06	6.82e-05	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—PIK3CA—hematologic cancer	4.82e-06	6.8e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—FBXW7—hematologic cancer	4.8e-06	6.77e-05	CbGpPWpGaD
Bumetanide—CA9—Metabolism—PIK3R1—hematologic cancer	4.77e-06	6.73e-05	CbGpPWpGaD
Bumetanide—CA4—Metabolism—PTEN—hematologic cancer	4.71e-06	6.65e-05	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—EP300—hematologic cancer	4.71e-06	6.65e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—HDAC2—hematologic cancer	4.7e-06	6.64e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—CXCR4—hematologic cancer	4.7e-06	6.64e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—GSTT1—hematologic cancer	4.69e-06	6.61e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—CD44—hematologic cancer	4.65e-06	6.56e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	4.61e-06	6.51e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—CBL—hematologic cancer	4.58e-06	6.47e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—SDC1—hematologic cancer	4.58e-06	6.46e-05	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	4.55e-06	6.42e-05	CbGpPWpGaD
Bumetanide—CA7—Metabolism—PIK3CA—hematologic cancer	4.5e-06	6.35e-05	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—PIK3CA—hematologic cancer	4.5e-06	6.35e-05	CbGpPWpGaD
Bumetanide—CA4—Metabolism—EP300—hematologic cancer	4.49e-06	6.34e-05	CbGpPWpGaD
Bumetanide—CA9—Metabolism—PIK3CB—hematologic cancer	4.41e-06	6.22e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	4.38e-06	6.17e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—HSP90AA1—hematologic cancer	4.37e-06	6.17e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—MTHFR—hematologic cancer	4.37e-06	6.16e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	4.32e-06	6.09e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—STAT1—hematologic cancer	4.22e-06	5.95e-05	CbGpPWpGaD
Bumetanide—CA12—Metabolism—PIK3CA—hematologic cancer	4.17e-06	5.88e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	4.13e-06	5.83e-05	CbGpPWpGaD
Bumetanide—CA14—Metabolism—AKT1—hematologic cancer	4.04e-06	5.7e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—GRB2—hematologic cancer	3.94e-06	5.57e-05	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—AKT1—hematologic cancer	3.94e-06	5.55e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—PDGFA—hematologic cancer	3.93e-06	5.55e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—NQO1—hematologic cancer	3.89e-06	5.49e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—CD44—hematologic cancer	3.89e-06	5.49e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—KITLG—hematologic cancer	3.88e-06	5.47e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.85e-06	5.43e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.81e-06	5.38e-05	CbGpPWpGaD
Bumetanide—CA9—Metabolism—PTEN—hematologic cancer	3.81e-06	5.37e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—STAT5A—hematologic cancer	3.79e-06	5.35e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—CDKN2B—hematologic cancer	3.76e-06	5.3e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—CYCS—hematologic cancer	3.69e-06	5.2e-05	CbGpPWpGaD
Bumetanide—CA7—Metabolism—AKT1—hematologic cancer	3.68e-06	5.19e-05	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—AKT1—hematologic cancer	3.68e-06	5.19e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—PIK3CG—hematologic cancer	3.67e-06	5.18e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—HSP90AA1—hematologic cancer	3.66e-06	5.17e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—CD86—hematologic cancer	3.63e-06	5.13e-05	CbGpPWpGaD
Bumetanide—CA9—Metabolism—EP300—hematologic cancer	3.63e-06	5.12e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—HES1—hematologic cancer	3.58e-06	5.06e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—NCOR1—hematologic cancer	3.56e-06	5.03e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—FGF1—hematologic cancer	3.52e-06	4.97e-05	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—PIK3CA—hematologic cancer	3.48e-06	4.92e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—FOXO1—hematologic cancer	3.47e-06	4.9e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—PDGFRB—hematologic cancer	3.47e-06	4.89e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—PDGFRA—hematologic cancer	3.41e-06	4.82e-05	CbGpPWpGaD
Bumetanide—CA12—Metabolism—AKT1—hematologic cancer	3.41e-06	4.8e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—CREBBP—hematologic cancer	3.4e-06	4.8e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—JAK1—hematologic cancer	3.4e-06	4.8e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—PRKCG—hematologic cancer	3.4e-06	4.8e-05	CbGpPWpGaD
Bumetanide—CA4—Metabolism—PIK3CA—hematologic cancer	3.32e-06	4.69e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.3e-06	4.65e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—GSTP1—hematologic cancer	3.25e-06	4.58e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—PIK3CD—hematologic cancer	3.23e-06	4.55e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—ALB—hematologic cancer	3.19e-06	4.49e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—MTHFR—hematologic cancer	3.15e-06	4.44e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.14e-06	4.43e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—TERT—hematologic cancer	3.14e-06	4.43e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—HLA-A—hematologic cancer	3.14e-06	4.43e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—ABCB1—hematologic cancer	3.07e-06	4.34e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—PDGFB—hematologic cancer	3.07e-06	4.33e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—PIK3R1—hematologic cancer	3.05e-06	4.3e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—TSC2—hematologic cancer	3e-06	4.23e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—NCOR1—hematologic cancer	2.99e-06	4.21e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—GSTM1—hematologic cancer	2.99e-06	4.21e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—FGFR3—hematologic cancer	2.88e-06	4.07e-05	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—AKT1—hematologic cancer	2.85e-06	4.02e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—PIK3CB—hematologic cancer	2.81e-06	3.97e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—BAD—hematologic cancer	2.73e-06	3.86e-05	CbGpPWpGaD
Bumetanide—CA4—Metabolism—AKT1—hematologic cancer	2.72e-06	3.83e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—NOTCH1—hematologic cancer	2.71e-06	3.82e-05	CbGpPWpGaD
Bumetanide—CA9—Metabolism—PIK3CA—hematologic cancer	2.69e-06	3.79e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—CD80—hematologic cancer	2.65e-06	3.74e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—KIT—hematologic cancer	2.65e-06	3.73e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—MTHFR—hematologic cancer	2.64e-06	3.72e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—PTPN11—hematologic cancer	2.6e-06	3.67e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—CREB1—hematologic cancer	2.52e-06	3.55e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—BRAF—hematologic cancer	2.49e-06	3.51e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—IL6R—hematologic cancer	2.46e-06	3.47e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—CREBBP—hematologic cancer	2.45e-06	3.46e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—PTEN—hematologic cancer	2.43e-06	3.43e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—MAP2K1—hematologic cancer	2.34e-06	3.3e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—PIK3CD—hematologic cancer	2.33e-06	3.28e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.32e-06	3.28e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—EP300—hematologic cancer	2.32e-06	3.27e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—FGF2—hematologic cancer	2.23e-06	3.14e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—PIK3CG—hematologic cancer	2.22e-06	3.13e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—PIK3R1—hematologic cancer	2.2e-06	3.1e-05	CbGpPWpGaD
Bumetanide—CA9—Metabolism—AKT1—hematologic cancer	2.19e-06	3.1e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—JAK2—hematologic cancer	2.14e-06	3.01e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—MDM2—hematologic cancer	2.08e-06	2.94e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—CREBBP—hematologic cancer	2.06e-06	2.9e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—PIK3CB—hematologic cancer	2.03e-06	2.86e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—MTOR—hematologic cancer	2.03e-06	2.86e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—CD4—hematologic cancer	2.02e-06	2.86e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—PIK3CD—hematologic cancer	1.95e-06	2.75e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—ALB—hematologic cancer	1.92e-06	2.71e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—CDKN1B—hematologic cancer	1.9e-06	2.69e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—PIK3R1—hematologic cancer	1.84e-06	2.6e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—CDKN1A—hematologic cancer	1.76e-06	2.48e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—PTEN—hematologic cancer	1.75e-06	2.47e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—PIK3CA—hematologic cancer	1.71e-06	2.42e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—PIK3CB—hematologic cancer	1.7e-06	2.4e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—EP300—hematologic cancer	1.67e-06	2.36e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—SRC—hematologic cancer	1.63e-06	2.29e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—STAT3—hematologic cancer	1.57e-06	2.21e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—NRAS—hematologic cancer	1.56e-06	2.21e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—MAPK3—hematologic cancer	1.5e-06	2.11e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—PTEN—hematologic cancer	1.47e-06	2.07e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—MYC—hematologic cancer	1.46e-06	2.05e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—TGFB1—hematologic cancer	1.45e-06	2.05e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—AKT1—hematologic cancer	1.4e-06	1.98e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—EP300—hematologic cancer	1.4e-06	1.97e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—KRAS—hematologic cancer	1.35e-06	1.9e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—PIK3CA—hematologic cancer	1.24e-06	1.74e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—HRAS—hematologic cancer	1.14e-06	1.61e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—IL6—hematologic cancer	1.09e-06	1.54e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—PIK3CA—hematologic cancer	1.04e-06	1.46e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—AKT1—hematologic cancer	1.01e-06	1.42e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—AKT1—hematologic cancer	8.46e-07	1.19e-05	CbGpPWpGaD
